4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-025193
CFO & Executive Vice President gave up 248 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Sharp Shalini · CFO & Executive Vice President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-04-19 | Shares withheld for taxes : show line 1 in the form | −248 | $58.57 | $14,525 | 103,584 | D |
Loading xslF345X03/doc4.xml…